Chronic hepatitis C virus infections in leukemia survivors: Prevalence, viral load, and severity of liver disease

Blood

Volumn 93, Issue 11, 1999, Pages 3672-3677

  Paul, Ian M ^a   Sanders, Jeffrey ^a   Ruggiero, Francesca ^a   Andrews, Thomas ^a   Ungar, David ^a   Eyster, M Elaine ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEPATITIS C ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CHRONIC HEPATITIS; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0033152321     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.11.3672     Document Type: Article

References (54)

1. Hetherington ML, Buchanan GR: Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlated with prior blood transfusions. Cancer 62:1614, 1988
2. Barrera JM, Bruguera M, Ercilla G, Sanchez-Tapias JM, Gil MP, Gil C, Costa J, Gelabert A, Rodes J, Castillo R: Incidence of non-A non B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 115:596, 1991
3. Lopez-Jiminez J, Cancelas JA, Garcia-Larana J, Sastre JL, Cervero C, Zamora C, Megido M, Hernandez-Jodra M, Lasa E, Perez-Oteyza J. Ramos P, Odriozola J, Navrro JL: Posttransfusion hepatitis after induction chemotherapy in acute nonlymphoblastic leukemia: Implications for long-term management and outcome. Transfusion 35:313, 1995
4. Murphy MF, Waters AH, Grint PCA, Hardiman AE, Lister TA: Hepatitis C infection in multitransfused patients with acute leukaemia. Lancet 335:58, 1990
5. Neilson JR, Harrison P, Skidmore SJ, King JA, Collingham KE, Milligan DW: Chronic hepatitis C in long term survivors of haematological malignancy treated in a single center. J Clin Pathol 49:230, 1996
6. Kolho E, Oksanen K, Honkanen E, Naukkarinen R, Krusius T: Hepatitis C antibodies in dialysis patients and patients with leukemia. J Med Virol 40:318, 1993
7. Fujii Y, Kaku K, Tanaka M, Yosiaki M, Kaneko T, Matumoto N: Hepatitis C virus infection in patients with leukemia. Am J Hematol 46:278, 1994
8. Ljundman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O, Sparrelid E, Sonneborg A, Winiarski J, Gahrton G: Long-term effects of hepatitis C virus infection in allogenic bone marrow transplant recipients. Blood 86:1614, 1995
9. Jackson SR, Carter JM, Jackson TW, Green GJ, Hawkins TE, Romeril K: Hepatitis C seroprevalence in bone marrow transplant recipients and hemophiliacs. N Z Med J 107:10, 1994
10. Fujii Y, Kaku K, Tanaka M, Kaneko T, Matumoto N, Shinohara K: Hepatitis C virus infection and liver disease after allogenic bone marrow transplantation. Bone Marrow Transplant 13:523, 1994
11. Kolho E, Ruutu P, Ruutu T: Hepatitis C infection in BMT patients. Bone Marrow Transplant 11:119, 1993
12. Locasciulli A, Bacigalupo A, Vanlint MT, Tagger A, Uderzo C, Portmann B, Shulman HM, Alberti A: Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 52:315, 1991
13. Norol F, Roche B, Girardin MSM, Kuentz M, Desforges L, Cordonnier C, Duedari N, Vernant J: Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 57:393, 1994
14. Tada K, Tajiri H, Kozaiwa K, Sawada A, Guo W, Okada S: Role of screening for hepatitis C virus in children with malignant disease who undergo bone marrow transplantation. Transfusion 37:641, 1997
15. Myers B, Irving W, Hollingsworth R, Readett D, Lilleyman JS, Dolan G: Hepatitis C virus infection in multi-transfused children with haematological malignancy. Br J Haematol 91:480, 1995
16. Cesaro S, Petris MG, Rossetti F, Cusinato R, Pipan C, Guido M, Masiero L, Botta GA, Meloni GA, Zanesco L: Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90:1315, 1997
17. Fink EM, Hocker-Schultz S, Mohr W, Puchhammer-Stockl E, Hoffmann H, Zoubek A, Pawlowsky J, Hocker P, Gardner H: Association of hepatitis C infection with chronic liver disease in pediatric cancer patients. Eur J Pediatr 152:490, 1993
18. Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli MU: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2919, 1994
19. Dibenedetto SP, Ragusa R, Sciacca A, Di Catuldo A, Miraglia V, D'Amico S, Lo Nigro L, Ippolito AM: Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. Eur J Pediatr 153:271, 1995
20. Locasciulli A, Testa M, Pontisso P, Benvegnu L, Fraschini D, Corbetta A, Noventa F, Masera G, Alberti A: Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90:4628, 1997
21. Eyster ME, Fried M, Di Bisceglie A, Goedert JJ: Increasing HCV RNA levels in hemophiliacs: Relationship to HIV infection and liver disease. Blood 84:1020, 1994
22. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE: Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 174:690, 1996
23. Sherman KE, O'Brien J, Gufierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J: Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 31:2679, 1993
24. Telfer PT, Brown D, Devereux H, Lee CA, DuSheiko GM: HCV RNA levels and HIV infection: Evidence for a viral interaction in haemophilic patients. Br J Haematol 88:397, 1994
25. Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Perez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D: Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. J Med Virol 52:219, 1997
26. Cribier B, Rey D, Schmitt C, Lang JM, Kim A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131, 1995
27. Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok ASF: Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 41:1265, 1996
28. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad MA, Rodriguez M, Sales Gilahert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26:1, 1997
29. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ: Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 6:602, 1993
30. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97: 1559, 1989
31. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C: The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 87:555, 1994
32. Hanley JP, Jarvis LM, Andrews J, Dennis R, Lee R, Simmonds P, Piris J, Hayes P, Ludlam CA: Investigation of chronic hepatitis C infection in individuals with haemophilia: Assessment of invasive and non-invasive methods. Br J Haematol 94:159, 1996
33. Makris M, Preston FE, Rosendaal FR, Underwood JCE, Rice KM, Triger DR: The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 94:746, 1996
34. Sanchez-Quijano A, Andreu J, Gavilan F, Luque F, Abad MA, Soto B, Munoz J, Aznar JM, Leal M, Lissen E: Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 14:949, 1995
35. Bjoro K, Froland SS, Yun Z, Samdal H, Haaland T: Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607, 1994
36. Rossi G, Tucci A, Cariani E, Ravagii A, Rossini A, Radaeli E: Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: Different prognosis according to the immune status. Blood 90:1309, 1997
37. Seeff L, Buskell-Bales Z, Wright E, Durako SJ, Alter HJ, Iber FL, Hollinger B, Gitnick G, Knodell RG, Stevens CE, Hollingsworth CG: Long term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906, 1992
38. Fletcher ML, Trowell JM, Craske J, Parier K, Rizza CR: Non-A, non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J Clin Res Ed 287:1754, 1983
39. Kernoff PB, Lee CA, Karayiannis P, Thomas HC: High risk of non-A, non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effects of prophylactic immune serum globulin. Br J Haematol 60:469, 1985
40. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431, 1981
41. Hawkins A, Davidson F, Simmonds P: Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, roche monitor assay, and an in-house limiting dilution method. J Clin Microbiol 35:187, 1997
42. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 334:1685, 1996
43. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671, 1990
44. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463, 1995
45. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lelkowitch JH, Ludwig J, Okuda K: The long term pathological evolution of chronic hepatitis C. Hepatology 23:1334, 1996
46. Gordon SC, Kodali VP, Silverman AL, Dmuchowski CR, Urdea MS, Chan CS, Wilber JC: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 89:1458, 1994
47. Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R, Busch M, Hart J, Sayers M, Han J: Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. J Infect Dis 169:1219, 1994
48. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T: Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 19:871, 1994
49. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339, 1992
50. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto M, Bonino F, Abrignani S: Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells for the protein N54 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17, 1993
51. Hiroshi K, Kita H, Kojima M, Okamoto H, Monyama T, Kaneko T, Ishikawa T, Onishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M: Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705, 1997
52. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY: The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158:1473, 1997
53. Thiele DL: Commentary: Liver injury associated with hepatitis C infection: Is it the virus or is it the host? Hepatology 26:238, 1997
54. Seeff LB, the NHLBI Study Group: Mortality and morbidity of transfusion associated non-A, non-B (NANB) and type C hepatitis: An NHLBI multi-center study. Hepatology 20:204a, 1994 (abstr)